PAI
UTHR icon

Pittenger & Anderson Inc’s United Therapeutics UTHR Stock Holding History

Pittenger & Anderson Inc’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.63K Buy
+3
New +$1.69K ﹤0.01% 478
2022
Q4 		– Sell
-5
Closed -$1K – 479
2022
Q3 		$1K Hold
5
– – ﹤0.01% 447
2022
Q2 		$1K Hold
5
– – ﹤0.01% 430
2022
Q1 		$1K Buy
+5
New +$953 ﹤0.01% 447

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

Pittenger & Anderson Inc's UTHR Position: Q2 2026 in Review

Pittenger & Anderson Inc opened a new position in United Therapeutics (UTHR) in Q2 2026: 3 shares worth $1.63K. The stake represents ﹤0.01% of the portfolio and ranks #478 among its holdings. This is a return to the name: Pittenger & Anderson Inc previously reported a position in UTHR as recently as Q3 2022.

Pittenger & Anderson Inc first reported a position in UTHR in Q1 2022 and has held it in 4 quarters since. 880 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • Pittenger & Anderson Inc held 3 shares of United Therapeutics worth $1.63K as of Q2 2026.
  • United Therapeutics was a new Pittenger & Anderson Inc position in Q2 2026.
  • United Therapeutics made up ﹤0.01% of Pittenger & Anderson Inc's portfolio in Q2 2026, its #478 holding.
  • Pittenger & Anderson Inc first reported a position in United Therapeutics in Q1 2022 and has held it in 4 quarters since.
  • 880 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on Pittenger & Anderson Inc's 13F filing for Q2 2026, filed 27 Jul 2026.